藥學前沿大講堂第141講-Synthesis and Antibacterial Activity of Thiazomycin Analogs （Thiazomycin結構類似物的合成及抗菌活性研究）

太阳集团1088vip十周年院慶系列活動­—

藥學前沿大講堂第141講

題  目：Synthesis and Antibacterial Activity of Thiazomycin Analogs （Thiazomycin結構類似物的合成及抗菌活性研究）

報告人：劉堃博士（Kun Liu, Ph.D.）

Director and Asia Lead External Medicinal Chemistry Merck Sharp & Dohme

主持人：鄢明 教授  太阳集团1088vip

時  間：2013年01月09日（周三） 上午10：30

地  點：中山大學東校區太阳集团1088vip 125講學廳

報告人簡介：

Kun Liu graduated from Fudan University in 1988 with a BS in Chemistry and completed his Ph.D. in 1995 at University of Rochester with Professor Andrew Kende. He then pursued a post-doctoral fellowship at Harvard University under Professor E. J. Corey before joining Merck in July 1997 as a Senior Research Chemist in the medicinal chemistry department at Rahway site.  He moved to Merck External Basic Research in May of 2008 as a Chemistry Collaboration Lead, responsible for the successful execution of drug discovery programs through external collaborations with biotechnology companies, contract research organizations, and academic institutions around the globe. In September of 2011, Kun was appointed Asia Lead of DPS and relocated to Shanghai.

Kun has drug discovery experience in multiple therapeutic areas, including diabetes, obesity, cardiovascular disease, oncology, infectious disease, and immunology, and has successfully advanced drug candidates to clinical development.  Dr. Liu served as an executive council member of Sino-American Pharmaceuticals Professional Association (SAPA). He has published over 30 papers in peer reviewed journals and holds more than 30 patents.

歡迎廣大師生踴躍參加！